A series of theoretical studies are proposed to develop and evaluate statistical approaches to resolving alternative hypotheses about the genetic and environmental determinants of aging and age-related diseases. Four approaches to the genetic analysis of age-related phenomena will be investigated: extension of time series models to incorporate genetic and environmental effects; analysis of the extent and cause of correlation between disease liability and age of onset; the statistical-genetic consequences of age-related degeneration of homeostatic control of gene regulation and sensitivity to the environment the incorporation of genetic and environmental heterogeneity into survival analysis models or age-dependent events. Computer programs will be developed to stimulate and analyze kinship data in each of the major areas of interest with the principal goal of deciding how far quantitative genetic studies of age related phenomena can elucidate the genetic and environmental processes underlying different aspects of the aging process. The resolving power of different strategies will be explored, and the effects of bias and errors of inference assessed. Appropriate methods will be applied to illustrative data from a large longitudinal study of cardiovascular risk in twins and their parents (N=330 families) and to a study of common age-dependent disease and disease-related risk factors in two large studies of twins and their relatives (N=5000 pairs and N=14000 twins plus 7000 relatives, approximately). By the end of the five year project the theoretical and computational tools available to genetic research into aging should be significantly enhanced.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG004594-06
Application #
3115239
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1984-01-01
Project End
1990-06-30
Budget Start
1989-04-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Bjorkman, S; Wada, D R; Stanski, D R (1998) Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 88:657-67
Wada, D R; Bjorkman, S; Ebling, W F et al. (1997) Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87:884-99
Harashima, H; Ebling, W F; Wada, D R et al. (1997) No effect of age on the dose requirement of thiopental in the rat. Exp Gerontol 32:315-24
Wada, D R; Harashima, H; Ebling, W et al. (1996) Effects of thiopental on regional blood flows in the rat. Anesthesiology 84:596-604
MacIver, M B; Mandema, J W; Stanski, D R et al. (1996) Thiopental uncouples hippocampal and cortical synchronized electroencephalographic activity. Anesthesiology 84:1411-24
Wada, D R; Stanski, D R; Ebling, W F (1995) A PC-based graphical simulator for physiological pharmacokinetic models. Comput Methods Programs Biomed 46:245-55
Bjorkman, S; Wada, D R; Stanski, D R et al. (1994) Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J Pharmacokinet Biopharm 22:381-410
Burm, A G; Ausems, M E; Spierdijk, J et al. (1993) Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery. Eur J Anaesthesiol 10:241-51
Bjorkman, S; Stanski, D R; Harashima, H et al. (1993) Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. J Pharmacokinet Biopharm 21:255-79
Verotta, D; Sheiner, L B (1991) Semiparametric analysis of non-steady-state pharmacodynamic data. J Pharmacokinet Biopharm 19:691-712

Showing the most recent 10 out of 28 publications